Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Sells]

IRWD Rating Summary

IRWD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IRWD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $14.90 (+34.1%) * Over Last 12-Mos
Rating Score: 3.8 / 10   Percentile Rank: 35%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/17/2013 Goldman Sachs New Coverage Sell
(N/A)
9.50
(N/A)
13.64 11.11 -18.55% Details
1/16/2013 UBS Downgrade Sell
(Neutral)
N/A
(N/A)
14.69 11.11 -24.37% Details
Like IRWD Ratings? Also take a look at SGYP, ACT, EXAS, AGN

IRWD Ratings News